Finance

Lists
950210:KRX
Prestige Biopharma Ltd
₩5,600.00
+1.08%
(+60.00) 1D
Oct 14, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 950210...
Open
₩5,840
High
₩5,840
Low
₩5,420
Mkt. cap
336.54B
Avg. vol.
34.68K
Volume
21.33K
52-wk high
₩14,120
52-wk low
₩4,945
EPS
-₩896
Shares outstanding
60.10M
No. of employees
64
Open
₩5,840
High
₩5,840
Low
₩5,420
Mkt. cap
336.54B
Avg. vol.
34.68K
Volume
21.33K
52-wk high
₩14,120
52-wk low
₩4,945
EPS
-₩896
Shares outstanding
60.10M
No. of employees
64
News stories
From web sources and news partners
About Prestige Biopharma Ltd
CEO-
Employees64
Founded2015
Headquarters-
SectorBiotechnology
Websiteprestigebiopharma.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.36B
7.81B
509.20M
15.39B
Cost of goods sold
2.23B
10.17B
12.23B
17.68B
Cost of revenue
2.23B
10.17B
12.23B
17.68B
Research and development expenses
-
-
-
42.51B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.95B
16.79B
14.63B
-36.73B
Operating expense
24.95B
16.79B
14.63B
20.81B
Total operating expenses
27.18B
26.96B
26.86B
38.49B
Operating income
-24.82B
-19.15B
-26.35B
-23.10B
Other non operating income
4.06B
-1.38B
-3.05B
7.24B
EBT including unusual items
-20.76B
-20.53B
-29.40B
-52.36B
EBT excluding unusual items
-20.76B
-20.53B
-29.40B
-23.56B
Income tax expense
-69.96M
-17.84M
-20.29M
-43.51M
Effective tax rate
0.34%
0.09%
0.07%
0.08%
Other operating expenses
-
-
-
573.69M
Net income
-12.62B
-15.37B
-20.56B
-42.95B
Net profit margin
-534.55%
-196.66%
-4,037.83%
-279.14%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
3.62B
Interest expense
-
-
-
-6.92B
Net interest expenses
-
-
-
-3.31B
Depreciation and amortization charges
-
-
-
6.52B
EBITDA
-19.37B
-13.70B
-20.90B
-14.91B
Gain or loss from assets sale
-
-
-
-6.37M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps